305 related articles for article (PubMed ID: 30645134)
1. Effect of Polymer Hydrophobicity on the Stability of Amorphous Solid Dispersions and Supersaturated Solutions of a Hydrophobic Pharmaceutical.
Frank DS; Matzger AJ
Mol Pharm; 2019 Feb; 16(2):682-688. PubMed ID: 30645134
[TBL] [Abstract][Full Text] [Related]
2. Probing the Interplay between Amorphous Solid Dispersion Stability and Polymer Functionality.
Frank DS; Matzger AJ
Mol Pharm; 2018 Jul; 15(7):2714-2720. PubMed ID: 29924614
[TBL] [Abstract][Full Text] [Related]
3. Polymeric Amorphous Solid Dispersions: A Review of Amorphization, Crystallization, Stabilization, Solid-State Characterization, and Aqueous Solubilization of Biopharmaceutical Classification System Class II Drugs.
Baghel S; Cathcart H; O'Reilly NJ
J Pharm Sci; 2016 Sep; 105(9):2527-2544. PubMed ID: 26886314
[TBL] [Abstract][Full Text] [Related]
4. Mid-infrared spectroscopy as a polymer selection tool for formulating amorphous solid dispersions.
Wegiel LA; Mauer LJ; Edgar KJ; Taylor LS
J Pharm Pharmacol; 2014 Feb; 66(2):244-55. PubMed ID: 24433425
[TBL] [Abstract][Full Text] [Related]
5. Moisture-Induced Amorphous Phase Separation of Amorphous Solid Dispersions: Molecular Mechanism, Microstructure, and Its Impact on Dissolution Performance.
Chen H; Pui Y; Liu C; Chen Z; Su CC; Hageman M; Hussain M; Haskell R; Stefanski K; Foster K; Gudmundsson O; Qian F
J Pharm Sci; 2018 Jan; 107(1):317-326. PubMed ID: 29107047
[TBL] [Abstract][Full Text] [Related]
6. Solubility advantage from amorphous etoricoxib solid dispersions.
Dani P; Puri V; Bansal AK
Drug Dev Ind Pharm; 2014 Jan; 40(1):92-101. PubMed ID: 23301771
[TBL] [Abstract][Full Text] [Related]
7. Investigation into the Solid-State Properties and Dissolution Profile of Spray-Dried Ternary Amorphous Solid Dispersions: A Rational Step toward the Design and Development of a Multicomponent Amorphous System.
Baghel S; Cathcart H; O'Reilly NJ
Mol Pharm; 2018 Sep; 15(9):3796-3812. PubMed ID: 30020788
[TBL] [Abstract][Full Text] [Related]
8. Amorphous stabilization and dissolution enhancement of amorphous ternary solid dispersions: combination of polymers showing drug-polymer interaction for synergistic effects.
Prasad D; Chauhan H; Atef E
J Pharm Sci; 2014 Nov; 103(11):3511-3523. PubMed ID: 25196860
[TBL] [Abstract][Full Text] [Related]
9. Phase Behavior of Resveratrol Solid Dispersions Upon Addition to Aqueous media.
Wegiel LA; Mosquera-Giraldo LI; Mauer LJ; Edgar KJ; Taylor LS
Pharm Res; 2015 Oct; 32(10):3324-37. PubMed ID: 25975588
[TBL] [Abstract][Full Text] [Related]
10. Impact of Polymer Enrichment at the Crystal-Liquid Interface on Crystallization Kinetics of Amorphous Solid Dispersions.
Zhang J; Shi Q; Tao J; Peng Y; Cai T
Mol Pharm; 2019 Mar; 16(3):1385-1396. PubMed ID: 30716277
[TBL] [Abstract][Full Text] [Related]
11. Phase behavior of poly(vinylpyrrolidone) containing amorphous solid dispersions in the presence of moisture.
Rumondor AC; Marsac PJ; Stanford LA; Taylor LS
Mol Pharm; 2009; 6(5):1492-505. PubMed ID: 19634917
[TBL] [Abstract][Full Text] [Related]
12. Dissolution Performance of High Drug Loading Celecoxib Amorphous Solid Dispersions Formulated with Polymer Combinations.
Xie T; Taylor LS
Pharm Res; 2016 Mar; 33(3):739-50. PubMed ID: 26563205
[TBL] [Abstract][Full Text] [Related]
13. Effects of polymer type and storage relative humidity on the kinetics of felodipine crystallization from amorphous solid dispersions.
Rumondor AC; Stanford LA; Taylor LS
Pharm Res; 2009 Dec; 26(12):2599-606. PubMed ID: 19806435
[TBL] [Abstract][Full Text] [Related]
14. Solution behavior of PVP-VA and HPMC-AS-based amorphous solid dispersions and their bioavailability implications.
Qian F; Wang J; Hartley R; Tao J; Haddadin R; Mathias N; Hussain M
Pharm Res; 2012 Oct; 29(10):2765-76. PubMed ID: 22315020
[TBL] [Abstract][Full Text] [Related]
15. Effect of hydrophilic additives on the dissolution and pharmacokinetic properties of itraconazole-enteric polymer hot-melt extruded amorphous solid dispersions.
Lang B; Liu S; McGinity JW; Williams RO
Drug Dev Ind Pharm; 2016; 42(3):429-45. PubMed ID: 26355819
[TBL] [Abstract][Full Text] [Related]
16. Determination of drug-polymer solubility from supersaturated spray-dried amorphous solid dispersions: A case study with Efavirenz and Soluplus®.
Costa BLA; Sauceau M; Del Confetto S; Sescousse R; Ré MI
Eur J Pharm Biopharm; 2019 Sep; 142():300-306. PubMed ID: 31247317
[TBL] [Abstract][Full Text] [Related]
17. Crystallization of amorphous solid dispersions of resveratrol during preparation and storage-Impact of different polymers.
Wegiel LA; Mauer LJ; Edgar KJ; Taylor LS
J Pharm Sci; 2013 Jan; 102(1):171-84. PubMed ID: 23132686
[TBL] [Abstract][Full Text] [Related]
18. Effect of polymer type on the dissolution profile of amorphous solid dispersions containing felodipine.
Konno H; Handa T; Alonzo DE; Taylor LS
Eur J Pharm Biopharm; 2008 Oct; 70(2):493-9. PubMed ID: 18577451
[TBL] [Abstract][Full Text] [Related]
19. Molecular implications of drug-polymer solubility in understanding the destabilization of solid dispersions by milling.
Yang Z; Nollenberger K; Albers J; Qi S
Mol Pharm; 2014 Jul; 11(7):2453-65. PubMed ID: 24897345
[TBL] [Abstract][Full Text] [Related]
20. Investigation into Intermolecular Interactions and Phase Behavior of Binary and Ternary Amorphous Solid Dispersions of Ketoconazole.
Sarpal K; Tower CW; Munson EJ
Mol Pharm; 2020 Mar; 17(3):787-801. PubMed ID: 31860316
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]